Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparin. [PDF]
van Haaps TF +11 more
europepmc +1 more source
Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections. [PDF]
Nageeb Mahmoud AM +3 more
europepmc +1 more source
Low-Molecular-Weight Heparin in Orthopedic Patients Taking Clopidogrel: A Focused Review. [PDF]
Mohamed A, Khan AU, Fuad U, Elasad A.
europepmc +1 more source
Low-molecular-weight heparin in patients with renal insufficiency
AG Fischer
doaj +1 more source
Low-Molecular-Weight Heparin in Preeclampsia: Effects on Biomarkers and Prevention: A Narrative Review. [PDF]
Baroutis D +9 more
europepmc +1 more source
Low Molecular Weight Heparin Thromboprophylaxis or No Treatment following Cesarean Delivery: A Pilot Randomized Controlled Trial. [PDF]
Bruno AM +4 more
europepmc +1 more source
Extended thromboprophylaxis after hip fracture surgery: Real-world evidence of direct oral anticoagulants versus low molecular weight heparin of unfractionated heparin. [PDF]
Clavijo MM +15 more
europepmc +1 more source
Perioperative prevention of venous thrombosis with low-molecular-weight heparin versus rivaroxaban in elderly patients with hip fractures: A retrospective controlled study. [PDF]
He X, Chen H, Lou F, Yan C, Feng J.
europepmc +1 more source
Multifunctional applications and research advances of low-molecular-weight heparin. [PDF]
Zhang Y, Guo S, Xu J.
europepmc +1 more source
Deep vein thrombosis incidence after sequential Low-molecular-weight heparin and Rivaroxaban versus no prophylaxis in posterior cruciate ligament avulsion fractures. [PDF]
Mithu MM +12 more
europepmc +1 more source

